Fig. 1 · Structure
Documents & Downloads
Wedeloside
Antitumor Compound
Wedeloside is a diterpenoid amino glycoside derived from Wedelia asperrima that exhibits antitumor properties. It effectively inhibits ADP-stimulated respiration in mitochondria, indicating its potential to disrupt cellular energy metabolism in cancer cells. This compound is useful for drug development and toxicological studies, providing insights into mechanisms of action and therapeutic efficacy in cancer research.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 74686-30-9 |
| Applications | Antitumor Compound |
| Formula | C40H55NO13 |
| Molecular Weight | 757.86 |
| SMILES | C=C([C@@](CC1)(O)C2)[C@H](O)[C@@]32CC[C@]4([H])C(C(O)=O)(C(O)=O)C[C@@H](O[C@H]5[C@H](NC(CC(C)C)=O)[C@H]([C@@H]([C@@H](CO)O5)O)OC(CCC6=CC=CC=C6)=O)C[C@@]4(C)[C@@]31[H] |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.